HIV

An increasing number of patients with HIV are 50 or older, which comes with new challenges for health care providers.

Acute infection screening program for HIV shows promise.

Study hopes to overcome significant challenges in producing an HIV vaccine.

Patients who enroll in studies, including those for pre-exposure prophylaxis, may share their medication with friends and family who have health concerns of their own or the same diagnoses.

Researchers evaluate mechanism that prevents immune system from attacking tumors in melanoma.

Immunotherapy combination increased T cell activity in the blood and the patient went into remission.

Denmark is close to eradicating HIV through a prevention approach.

Association found between persistent immune activation, arterial inflammation, and plaque development in HIV

The critical beginning stages of HIV have been found to be less symptomatic than previously thought.

Are you an HIV expert or amateur?

Researchers evaluate why HIV-infected individuals have lower magnitude responses to flu vaccines.

As the name suggests, human immunodeficiency virus is all about lowered immunity.

CRISPR/Cas9 gene editing system shows promise eliminating HIV.

The United States decreased the rate of HIV incidence and transmission, but not enough to meet the goals outlined in 2010.

Researchers found that 80% of HIV-positive patients had increased aortic inflammation after starting antiretroviral therapy.

The protein PSGL-1 can increase or inhibit the activity of T cells.

Specific venoms may lead to targeted therapies for conditions such as multiple sclerosis, rheumatoid arthritis, and other inflammatory disorders.

Neutron crystallography improves insight about the enzyme HIV-1 protease.

Certain patients can kill HIV antigens before an infection is developed.

HIV knowledge is a significant predictor of the willingness to provide services to patients with HIV.

Researchers found that an optimal adherence of 80 to 90% may be a more accurate HIV therapeutic goal.

Experimental treatment shows promise attacking tumor cells.

Ineffective antiretroviral regimens, improper dosing, and drug interactions are the most common medication errors in HIV patients.

Pharmacy schools may want to consider placing a greater focus on HIV education, since a new study suggests there's still HIV stigma among some pharmacy students.

The transition from an acute hospitalization back into the community introduces ample opportunities for medication errors, and HIV patients who need dosage adjustments and intense monitoring are particularly liable to them.